Pharmacists play a key role and are often the first point of contact for people with wounds, both chronic and acute. During the COVID-19 pandemic, this has only become more apparent.
The burden of wound care is increasing through the ageing population, growing comorbidities and increased skin integrity issues (Guest et al, 2015; Guest et al, 2020), with the annual prevalence of wounds increasing by 71% between 2012/2013 and 2017/2018 (Guest et al, 2020) – and with many people being reluctant to go into the hospital or primary care setting, the key role of the pharmacist will continue to develop and grow … read more
Kent Imaging has announced Health Canada’s approval for SnapshotNIR V3.0 (KD204) – now available for shipping in both official languages. This upgrade provides significant feature enhancements to the imaging technology that advances tissue assessment in acute and chronic wounds. The multitude of features include the ability to image most skin tones (overcoming the melanin barrier), linear and surface area wound measurements, easy report generation with image comparisons, and enhanced patient file management, to name a few.
“As a firmly Canadian company, we are excited to release this enhanced version of SnapshotNIR into the country. This is another critical step in our goal of delivering effective wound care and surgical solutions to care providers and improving patient outcomes,” says Pierre Lemire, Kent’s CEO. “The updates to SnapshotNIR V3.0 will make it easier and faster than ever to bring critical real-time and point-of-care data to the treatment path.”
SnapshotNIR utilizes near-infrared light to determine tissue oxygen saturation (StO2), which is a key indicator of tissue health. Ideal for microcirculation assessment, it conveys a comprehensive picture of the healing capacity of wounds or surgical tissue. This critical information is used to support clinical judgment in choosing, evaluating, and tracking treatment and surgical options throughout the care continuum … read more
Selecting the appropriate dressing for the individual is essential in promoting optimum healing, symptom management, comfort and overall quality of life for the patient. This Made Easy describes SMARTPORE Technology®, utilised in the BETAplast® dressing range (Mundipharma). SMARTPORE Technology® provides high absorption and retention of exudate, along with an optimal moisture vapour transmission rate (MVTR), creating an ideal option for wound healing.
SMARTPORE TECHNOLOGY MADE EASY
Surgical wound dehiscence (SWD) is almost certainly under-reported, not least because of variation in the interpretation of what constitutes SWD. As a result, patients with SWD may not receive optimal treatment and may experience additional surgical site complications, increased mortality, prolonged hospital stays and readmission. Following a meeting in July 2017, an international panel of clinical experts developed a consensus document to raise awareness of SWD, to aid identification of patients at increased risk and to provide practical guidance in prevention and management. This document has the endorsement of the World Union of Wound Healing Societies (WUWHS) and ultimately aims to improve outcomes for patients … read more